Comparing clinical outcomes of Schirmer's test with dry eye

Video

Jeffrey Gemi, MD, Ora Inc., speaks on the highlights from his presentation comparing Schirmer's test with other clinical outcomes in dry eye.

Jeffrey Gemi, MD, director of Special Projects, Anterior Segments, Ora Inc., speaks on the highlights from a presentation on comparing Schirmer's test with other clinical outcomes in dry eye during the virtual ARVO 2021 meeting.

See more ARVO content

Recent Videos
Thomas Aaberg, MD, gives an update on Neurotech Pharmaceuticals NT-501 device for the potential treatment of retinitis pigmentosa and age-related macular degeneration, including a projected PDUFA date from the FDA at the annual ASRS meeting in Stockholm, Sweden.
Sruthi Arepalli, MD, spoke with Modern Retina about her presentation, "Assessing retinal vascular changes in alzheimer disease with radiomics: A preliminary study of fundus photography" at the annual ASRS meeting in Stockholm, Sweden.
Nathan Steinle, MD, spoke with Modern Retina about the ongoing research on the durability of sozinibercept in combination therapy with anti-VEGF-A treatments at the annual ASRS meeting in Stockholm, Sweden.
Deepak Sambhara, MD, shared an overview of his paper-on-demand, which covered real-world safety and efficacy of aflibercept, 8 mg in the treatment of neovascular age-related macular degeneration at the annual ASRS meeting in Stockholm, Sweden.
Professor Shahina Pardhan, BSC, PhD, MBCO, H DHealth Brad, Director of the Vision and Eye Research Institute, School of Medicine, at Anglia Ruskin University in Cambridge, United Kingdom.
Penny A Asbell, MD, FACS speaks at the 2023 AAO meeting
Dr Mary Elizabeth Hartnett speaks with David Hutton of Ophthalmology Times
Related Content
An architectural impression of the Oriel eye health centre exterior. Rendering courtesy Moorfields Eye Charity.

Impact report highlights outcomes of Moorfields Eye Charity programmes

Hattie Hayes
July 12th 2024
Article

The organisation has secured £72.75 million for its new eye health centre

PHOTON Results and Their Relation to DME Patients in Your Practice

PHOTON Results and Their Relation to DME Patients in Your Practice

July 25th 2024
Podcast

John Kitchens, MD, is joined by Diana Do, MD, to discuss the PHOTON trial results and their relation to patients with diabetic macular oedema in clinical practice.

A black background with a red line graph going down. Image credit: ©Who is Danny – stock.adobe.com

Increase in the incidence rate of conjunctival melanoma in Australia

Lynda Charters
March 28th 2024
Article

Investigators analysed the incidence and mortality rates from conjunctival melanoma cases over a 32-year period

PULSAR Results and Their Relation to nAMD Patients in Your Practice

PULSAR Results and Their Relation to nAMD Patients in Your Practice

July 24th 2024
Podcast

John Kitchens, MD, is joined by David Brown, MD, to discuss the PULSAR study results and their relation to patients with neovascular age-related macular degeneration in clinical practice.

An elderly woman clutches her forehead in pain. Image credit: ©Tom Wang – stock.adobe.com

COPHy 2024: Should all elderly patients with acute visual loss go to the emergency department?

Lynda Charters
March 16th 2024
Article

A case study emphasises the shifting paradigm in clinical best practices

A sign outside the US FDA office. Image credit: ©JHVEPhoto – stock.adobe.com

United States FDA approves clobetasol propionate ophthalmic suspension 0.05% from Formosa Pharmaceuticals and AimMax Therapeutics

Sydney M Crago;Emily Kaiser Maharjan;Hattie Hayes
March 5th 2024
Article

The approval marks the first new steroid on the US ophthalmic market in more than 15 years

© 2024 MJH Life Sciences

All rights reserved.